Raymond James Financial’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

Raymond James Financial’s Portfolio CSCI Stock Details CSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2	Closed	-$7	–	6923
2025 Q2	$7	Buy	+2	New	+$7	﹤0.01%	6950

Other funds holding CSCI

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Raymond James Financial's CSCI Position: Q3 2025 in Review

Raymond James Financial sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2025, closing a stake of 2 shares — an estimated $7 sold.

Raymond James Financial first reported a position in CSCI in Q2 2025 and held it in 1 quarter. The position peaked at $7 in Q2 2025. 2 funds tracked by Wall St. Rank hold CSCI as of Q3 2025.

Raymond James Financial reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
Raymond James Financial sold 2 COSCIENS Biopharma Inc. Common Stock shares in Q3 2025, an estimated $7.
Raymond James Financial first reported a position in COSCIENS Biopharma Inc. Common Stock in Q2 2025 and held it in 1 quarter.
Raymond James Financial's COSCIENS Biopharma Inc. Common Stock position peaked at $7 in Q2 2025.
2 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.